Compare Global X Cybersecurity (BUG) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Cybersecurity vs Novo Nordisk A/S — how do they compare? Global X Cybersecurity trades at $42.48, while Novo Nordisk A/S trades at $49.22 (market cap $218.15B). The key difference: Novo Nordisk A/S pays a 3.66% dividend while Global X Cybersecurity pays none, and Global X Cybersecurity is trading nearer its 52-week high, Novo Nordisk A/S nearer its low. Which is the better fit depends on your goals.
| BUG | NVO | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $41.99 | $71.70 |
52-Week Low | $23.30 | $35.29 |
Market Cap | — | $218.15B |
Enterprise Value | — | $237.11B |
Dividend Yield | — | 3.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Cybersecurity
BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.
Read more on BUG →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
